Clik here to view.
Alcon Strengthens Leadership in IOL Innovation with the launch of the Clareon...
BENGALURU, India Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the launch of the Clareon® Family of intraocular lenses (IOLs) in...
View ArticleClik here to view.
TRACT Therapeutics and Taiwan Bio Therapeutics Announce Poster Presentation...
CHICAGO & TAIPEI, Taiwan TRACT Therapeutics and Taiwan Bio Therapeutics are pleased to announce a poster presentation at the 2024 annual meeting of the American Transplant Congress (ATC) taking...
View ArticleClik here to view.
Saghmos Therapeutics Announces Receipt of Notice of Allowance from Japanese...
GREENWICH, Conn. Saghmos Therapeutics, Inc. (Saghmos), a privately held biopharmaceutical company, announced that it has received a Notice of Allowance from the Japanese Patent Office for a patent...
View ArticleClik here to view.
Northern Trust Releases 2023 Philanthropic Impact Report
CHICAGO Northern Trust (Nasdaq: NTRS) donated more than $170 million over the past decade to non-profit organizations, including nearly $16 million in 2023 to organizations working to provide food...
View ArticleClik here to view.
Takeda Announces Positive Topline Results from Phase 2 Study Evaluating...
OSAKA, Japan & CAMBRIDGE, Mass. Takeda (TSE:4502/NYSE:TAK) today announced positive topline results from a Phase 2, randomized, double-blind, placebo-controlled study evaluating the safety,...
View ArticleClik here to view.
Aptar Pharma Continues Global Expansion with North America Capacity Extension...
CRYSTAL LAKE, Ill. Aptar Pharma, part of AptarGroup, Inc., a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced the next phase of its global...
View ArticleClik here to view.
Startup Ecosystem in TAKANAWA GATEWAY CITY
TOKYO East Japan Railway Company: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240313677655/en/ Startup Ecosystem (Graphic: Business...
View ArticleClik here to view.
BeiGene Receives FDA Approval for TEVIMBRA® for the Treatment of Advanced or...
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass. BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration...
View ArticleClik here to view.
BeiGene、化学療法後の進行性または転移性食道扁平上皮癌の治療のためのTEVIMBRA®のFDA承認取得
スイス・バーゼル、北京、マサチューセッツ・ケンブリッジ （ビジネスワイヤ） — グローバルな腫瘍学企業であるBeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235)...
View ArticleClik here to view.
Otsuka and Lundbeck Present New Data Analyses on the Efficacy of REXULTI®...
PRINCETON, N.J. & DEERFIELD, Ill. Otsuka Pharmaceutical Development & Commercialization, Inc. (Otsuka) and Lundbeck U.S., the U.S. subsidiaries of H. Lundbeck A/S, (Lundbeck) presented new...
View ArticleClik here to view.
JCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo®...
HYOGO, Japan JCR Pharmaceuticals Co., Ltd. (TSE 4552; Chairman and President: Shin Ashida; “JCR”) today announced that it has achieved the first research milestone criterion in a collaboration with...
View ArticleClik here to view.
Charles River Announces Extension of Gene Therapy Manufacturing Alliance with...
WILMINGTON, Mass. Charles River Laboratories International, Inc. (NYSE: CRL) and National University of Singapore’s (NUS) Yong Loo Lin School of Medicine (NUS Medicine), a leading medical education...
View ArticleClik here to view.
Otsuka Announces Interim Data from Phase 2b/c Trial Indicating New...
PRINCETON, N.J. & TOKYO Otsuka Pharmaceutical Development & Commercialization, Inc., and our parent company Otsuka Pharmaceutical, Co. Ltd., announce that interim data from a Phase 2b/c...
View ArticleClik here to view.
Cargill and Water.org Announce $2.1 Million Partnership to Provide Access to...
WAYZATA, Minn. Reliable access to clean, safe water as well as sanitation and hygiene are essential for communities to thrive. To help expand water access, Cargill has committed $2.1 million in...
View ArticleClik here to view.
Yes! We Can End TB ＆ AIDS, Says AHF
LOS ANGELES Join AIDS Healthcare Foundation (AHF) this World Tuberculosis (TB) Day, recognized annually on March 24, to raise awareness of one of the world’s deadliest infectious diseases, which is...
View ArticleClik here to view.
Toyoda Gosei Invests in Yuurea, Inc., a Startup Developing Urine Test Kits...
KIYOSU, Japan Toyoda Gosei Co., Ltd. (TOKYO:7282), as one part of its efforts to develop new businesses that will help to resolve societal challenges in the healthcare field, has invested* in...
View ArticleClik here to view.
New Findings From Sunbird Bio Reveal Significant Potential of Specific Tau...
CAMBRIDGE, Mass. & SINGAPORE Sunbird Bio, a biotechnology company developing proprietary protein- and blood-based technologies to improve diagnosis and treatment of neurological disorders and...
View ArticleClik here to view.
Takeda Announces Approval of ADZYNMA® Intravenous Injection 1500 (apadamtase...
OSAKA, Japan & CAMBRIDGE, Mass. Takeda (TSE: 4502/NYSE:TAK) today announced that the Japanese Ministry of Health, Labour and Welfare has approved the use of ADZYNMA (apadamtase alfa...
View ArticleClik here to view.
领先的合同开发和制造组织PCI Pharma Services发布首份综合ESG报告
费城 (美国商业资讯)– 全球领先的合同开发和制造组织(CDMO) PCI Pharma Services（以下简称“PCI”）发布了其首份 环境、社会和治理(ESG)报告 。该报告详细概述了PCI多方面的可持续发展历程，展示了该计划自2021年正式启动至2023财年期间所取得的长足进步，并提出了在多个方面继续取得进展的宏伟目标。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
大手CDMOのPCIファーマ・サービシズが初の包括ESG報告書を発表
フィラデルフィア （ビジネスワイヤ） — 世界有数の医薬品開発・製造受託機関（CDMO）であるPCIファーマ・サービシズ（以下「PCI」といいます）は、初の 環境・社会・ガバナンス（ESG）報告書...
View Article